PK, PD, Safety and Tolerability of Lipegfilgrastim in Healthy Japanese and Caucasian Participants

NCT02306915 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

48

Enrollment

INDUSTRY

Sponsor class

Conditions

Pharmacokinetics
Pharmacodynamics

Interventions

DRUG: lipegfilgrastim

Sponsor

Merckle GmbH